From Medscape Ophthalmology

American Glaucoma Society (AGS) 24th Annual Meeting

February 27 - March 02, 2014; Washington, DC

This coverage is not sanctioned by, nor a part of, the American Glaucoma Society.

AGS Ex-PRESS Shunt 3-Year Outcomes Don't Top Trabeculectomy There is little additional long-term benefit with the Ex-PRESS Glaucoma Filtration Device, but debate continues about the cost-benefit of its short-term advantages, 2 new studies suggest.
Medscape Medical News, March 2014
AGS Most Bilateral Laser Iridotomy Patients Don't Require Meds Most people don't need medications before or after iridotomy, but those who need them before are likely to need them after, a new analysis shows.
Medscape Medical News, March 2014
AGS Injection May Replace Drops to Lower Intraocular Pressure A single injection of a nanoliposomal formulation of latanoprost significantly reduced pressure in patients with ocular hypertension or glaucoma, researchers report.
Medscape Medical News, March 2014
AGS Visual Field Index Overlooks Neural Loss in Early Glaucoma Far more retinal ganglion cells are lost in early disease than the index calculates, according to a study of more than 1200 eyes.
Medscape Medical News, March 2014

AGS Healthy Diet May Reduce Risk for Exfoliation Glaucoma Data from the Nurses' Health Study and the Health Professionals Follow-up Study suggest that a diet rich in folate helps prevent exfoliation glaucoma.
Medscape Medical News, March 2014
AGS Glaucoma Shunt Comparison Yields Key Differences at 5 Years Long-term intraocular pressure was higher with the Ahmed glaucoma valve, and serious complications were more common with the Baerveldt implant.
Medscape Medical News, March 2014
AGS Expensive Tube-Shunt Surgery Cost-Effective in Glaucoma Lower rates of failure and reoperation make the Baerveldt tube shunt cost-effective, despite being more expensive than trabeculectomy, a new study shows.
Medscape Medical News, February 2014

Previous Coverage

Related Resource